The role of structured inpatient lipid protocols in optimizing non-statin lipid lowering therapy: a review and single-center experience

Chad Gier; Ian Gilchrist; Matthew Fordham; Luke Riordan; Ella Milchan; Nidhi Patel; Azad Mojahedi; Sahana Choudhury; Tara Kits; Regina Cohen; Joseph Doughtery; John P. Reilly; Andreas Kalogeropoulos; Tahmid Rahman; On Chen

doi:10.3389/fcvm.2024.1284562

Frontiers in Cardiovascular Medicine (Jan 2024)

The role of structured inpatient lipid protocols in optimizing non-statin lipid lowering therapy: a review and single-center experience

Chad Gier,
Ian Gilchrist,
Matthew Fordham,
Luke Riordan,
Ella Milchan,
Nidhi Patel,
Azad Mojahedi,
Sahana Choudhury,
Tara Kits,
Regina Cohen,
Joseph Doughtery,
John P. Reilly,
Andreas Kalogeropoulos,
Tahmid Rahman,
On Chen

Affiliations

Chad Gier: Stony Brook Heart Institute, Stony Brook University Hospital, Stony Brook, NY, United States
Ian Gilchrist: Stony Brook Heart Institute, Stony Brook University Hospital, Stony Brook, NY, United States
Matthew Fordham: Stony Brook Heart Institute, Stony Brook University Hospital, Stony Brook, NY, United States
Luke Riordan: Stony Brook Heart Institute, Stony Brook University Hospital, Stony Brook, NY, United States
Ella Milchan: Stony Brook Renaissance School of Medicine, Stony Brook, NY, United States
Nidhi Patel: Stony Brook Renaissance School of Medicine, Stony Brook, NY, United States
Azad Mojahedi: Stony Brook Renaissance School of Medicine, Stony Brook, NY, United States
Sahana Choudhury: Stony Brook Heart Institute, Stony Brook University Hospital, Stony Brook, NY, United States
Tara Kits: Stony Brook Heart Institute, Stony Brook University Hospital, Stony Brook, NY, United States
Regina Cohen: Stony Brook Heart Institute, Stony Brook University Hospital, Stony Brook, NY, United States
Joseph Doughtery: Stony Brook Heart Institute, Stony Brook University Hospital, Stony Brook, NY, United States
John P. Reilly: Stony Brook Heart Institute, Stony Brook University Hospital, Stony Brook, NY, United States
Andreas Kalogeropoulos: Stony Brook Heart Institute, Stony Brook University Hospital, Stony Brook, NY, United States
Tahmid Rahman: Stony Brook Heart Institute, Stony Brook University Hospital, Stony Brook, NY, United States
On Chen: Stony Brook Heart Institute, Stony Brook University Hospital, Stony Brook, NY, United States

DOI: https://doi.org/10.3389/fcvm.2024.1284562
Journal volume & issue: Vol. 11

Abstract

Read online

Dyslipidemia is a leading contributor to atherosclerotic cardiovascular disease (ASCVD). There has been a significant improvement in the treatment of dyslipidemia in the past 10 years with the development of new pharmacotherapies. The intent of this review is help enhance clinicians understanding of non-statin lipid lowering therapies in accordance with the 2022 American College of Cardiology Expert Consensus Clinical Decision Pathway on the Role of Non-statin Therapies for LDL-Cholesterol Lowering. We also present a single-center experience implementing a systematic inpatient protocol for lipid lowering therapy for secondary prevention of ASCVD.

Published in Frontiers in Cardiovascular Medicine

ISSN: 2297-055X (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
Website: https://www.frontiersin.org/journals/cardiovascular-medicine

About the journal

Abstract

Keywords